Director, AI/ML MIDD Oncology Clinical Pharmacology, Modeling and Simulation
Lead and execute model-based drug development strategies in oncology, applying advanced pharmacometric and AI/ML techniques to optimize dose selection, trial design, and regulatory submissions. Drive innovation in clinical pharmacology through cross-functional collaboration and external engagement. Operate in a science-driven environment focused on accelerating the development of novel cancer therapies.